CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleLevered free cash flow is $18.25M, above the global median of $16.24M
- FinancialsAltman Z-Score 4.22: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.37%
Annual Rate
INR 3.00Paid semi-annual
Payout Ratio
17.7%Sustainable
Next Ex-Dividend
Sep 15, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
74.07BINR773.71M · vs all stocks (USD)
Trailing P/E
38.54xRevenue (TTM)
19.69BINR205.69M · vs all stocks (USD)
Profit Margin
10.40%Beta
0.2320xvs all stocks
52-Week Change
-5.38%vs all stocks
Forward Annual Dividend Yield
0.37%vs all stocks
Market Capitalization
74.07BINR773.71M · vs all stocks (USD)
Enterprise Value
83.45BINR871.75M · vs all stocks (USD)
Trailing P/E
38.54xForward P/E
32.53xPEG Ratio
0.7158xPrice to Sales (TTM)
3.82xPrice to Book (MRQ)
3.54xEnterprise to Revenue
4.24xEnterprise to EBITDA
18.98xGross Margin
55.84%Profit Margin
10.40%Operating Margin
19.15%Return on Assets (TTM)
5.02%Return on Equity (TTM)
8.22%Revenue (TTM)
19.69BINR205.69M · vs all stocks (USD)
Revenue per Share (TTM)
217.16INRUpdated Aug 21, 2026Quarterly Revenue Growth
38.70%Gross Profit (TTM)
10.67BINR111.46M · vs all stocks (USD)
EBITDA (TTM)
4.52BINR47.18M · vs all stocks (USD)
Net Income (TTM)
2.05BINR21.40M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
53.80%Operating Cash Flow (TTM)
2.62BINR27.36M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
1.75BINR18.25M · vs all stocks (USD)
Forward Annual Dividend Rate
3.00INRUpdated Aug 21, 2026Forward Annual Dividend Yield
0.37%vs all stocks
Trailing Annual Dividend Rate
4.00INRUpdated Aug 21, 2026Trailing Annual Dividend Yield
0.49%vs all stocks
Payout Ratio
17.73%Revenue
18.19BINRFY2026 · Mar 31, 2026Cost of Goods Sold
8.35BINRFY2026 · Mar 31, 2026Gross Profit
9.85BINRFY2026 · Mar 31, 2026Operating Income
2.98BINR31.14M · vs all stocks (USD)
Pre-tax Income
2.33BINRFY2026 · Mar 31, 2026Income Tax Expense
582.14MINRFY2026 · Mar 31, 2026Net Income
1.75BINRFY2026 · Mar 31, 2026EBIT
2.80BINRFY2026 · Mar 31, 2026EBITDA (Income Statement)
3.87BINRFY2026 · Mar 31, 2026Other Operating Expenses
4.09BINRFY2026 · Mar 31, 2026Non-operating Interest Expense
469.03MINRFY2026 · Mar 31, 2026EPS (Basic)
19.27INRFY2026 · Mar 31, 2026EPS (Diluted)
19.25INRFY2026 · Mar 31, 2026Basic Shares Outstanding
90.66MSharesFY2026 · Mar 31, 2026Diluted Shares Outstanding
90.66MSharesFY2026 · Mar 31, 2026Net Income from Continuing Operations
2.28BINRFY2026 · Mar 31, 2026Minority Interests (P&L)
0.00INRFY2026 · Mar 31, 2026Preferred Stock Dividends
0.00INRFY2026 · Mar 31, 2026Operating Cash Flow
891.94MINRFY2026 · Mar 31, 2026Free Cash Flow
-3.20BINRFY2026 · Mar 31, 2026Cash & Cash Equivalents (End of Period)
85.30MINRFY2026 · Mar 31, 2026Starting Profit (CF Statement)
2.28BINRFY2026 · Mar 31, 2026Other Non-cash Items
386.81MINRFY2026 · Mar 31, 2026Change in Accounts Receivable (CF)
-992.76MINRFY2026 · Mar 31, 2026Change in Other Assets/Liabilities
-779.28MINRFY2026 · Mar 31, 2026Capital Expenditures
-4.09BINRFY2026 · Mar 31, 2026Net Intangibles (CF)
-389.46MINRFY2026 · Mar 31, 2026Other Investing Activity
29.45MINRFY2026 · Mar 31, 2026Net Investing Cash Flow
-4.06BINRFY2026 · Mar 31, 2026Net Short-term Debt Issuance
1.58BINRFY2026 · Mar 31, 2026Common Dividends Paid
-362.59MINRFY2026 · Mar 31, 2026Other Financing Charges
-1.00KINRFY2026 · Mar 31, 2026Net Financing Cash Flow
1.22BINRFY2026 · Mar 31, 2026Shares Outstanding
90.68MSharesUpdated Aug 21, 2026Float Shares
47.91MSharesUpdated Aug 21, 2026% Held by Insiders
44.12%vs all stocks
% Held by Institutions
12.62%vs all stocks
Total Cash (MRQ)
96.16MINR1.00M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.06INRUpdated Aug 21, 2026Total Debt (MRQ)
7.94BINR82.91M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.3736xCurrent Ratio (MRQ)
1.49xBook Value per Share (MRQ)
234.28INRUpdated Aug 21, 2026Total Assets
34.82BINR363.70M · vs all stocks (USD)
Total Current Assets
13.97BINRFY2026 · Mar 31, 2026Total Liabilities
13.57BINRFY2026 · Mar 31, 2026Total Non-current Assets
20.84BINRFY2026 · Mar 31, 2026Total Non-current Liabilities
4.20BINRFY2026 · Mar 31, 2026Total Current Liabilities
9.38BINRFY2026 · Mar 31, 2026Cash & Cash Equivalents
85.30MINRFY2026 · Mar 31, 2026Other Short-term Investments
10.86MINRFY2026 · Mar 31, 2026Accounts Receivable
5.83BINRFY2026 · Mar 31, 2026Inventory
6.40BINRFY2026 · Mar 31, 2026Accounts Payable
3.35BINRFY2026 · Mar 31, 2026Short-term Debt
5.16BINRFY2026 · Mar 31, 2026Other Current Liabilities
103.06MINRFY2026 · Mar 31, 2026Long-term Debt
2.38BINRFY2026 · Mar 31, 2026Other Non-current Liabilities
1.00KINRFY2026 · Mar 31, 2026Common Stock (Book)
453.29MINRFY2026 · Mar 31, 2026Total Shareholders' Equity
21.25BINR221.94M · vs all stocks (USD)
52-Week Low
585.00INRUpdated Aug 21, 202652-Week High
946.10INRUpdated Aug 21, 202652-Week Change
-5.38%vs all stocks
Beta
0.2320xvs all stocks
50-Day MA
713.32INRUpdated Aug 21, 2026200-Day MA
711.98INRUpdated Aug 21, 2026Avg 10-Day Volume
2.41MSharesUpdated Aug 21, 2026Avg 30-Day Volume
897.50KSharesUpdated Aug 21, 2026Diluted EPS (TTM)
21.52INRUpdated Aug 21, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 4.22: safe zoneNotable
Altman Z-Score: 4.22
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Levered free cash flow is $18.25M, above the global median of $16.24MNotable
Levered free cash flow (USD): 18,249,924.558Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Tong Ren Tang Technologies Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Guizhou Sanli Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Chongqing Lummy Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
ChemPartner Pharmatech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Si-Bone Inc.
Tier 1ProductionApproval-Gated PipelineRule
Beta Bionics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Genomma Lab Internacional S.A.B. de C.V.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Design Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Jiangsu Jibeier Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
CytomX Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk